(Q43031106)

English

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study (English)

1 reference

Europe PubMed Central

12 November 2017

author name string

Izumi N

1

1 reference

Europe PubMed Central

12 November 2017

Kumada H

2

1 reference

Europe PubMed Central

12 November 2017

Hashimoto N

3

1 reference

Europe PubMed Central

12 November 2017

Harada H

4

1 reference

Europe PubMed Central

12 November 2017

Imawari M

5

1 reference

Europe PubMed Central

12 November 2017

Zeniya M

6

1 reference

Europe PubMed Central

12 November 2017

Toda G

7

1 reference

Europe PubMed Central

12 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

12 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

12 November 2017

46

1 reference

Europe PubMed Central

12 November 2017

3

1 reference

Europe PubMed Central

12 November 2017

516-523

1 reference

Europe PubMed Central

12 November 2017

https://scigraph.springernature.com/pub.10.1023/a:1005686829416

0 references

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamics of hepatitis C viremia following interferon-alpha administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A second group of hepatitis C viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11318525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1005686829416

1 reference

Europe PubMed Central

12 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43031106&oldid=1977643649"